Page 92 - EJMO-9-3

Eurasian Journal of
Medicine and Oncology Mapping breast cancer PPI networks for targets

doi: 10.1126/science.1235122 focus on differentially essential genes in human cancer cell
lines. Nucleic Acids Res. 2016;44(D1):D1057-D1063.
24. Madkour MM, Anbar HS, El-Gamal MI. Current status and
future prospects of p38α/MAPK14 kinase and its inhibitors. doi: 10.1093/nar/gkw1013
Eur J Med Chem. 2021;213:113216.
36. Chen WH, Trachana K, Lercher MJ, Bork P. Younger genes
doi: 10.1016/j.ejmech.2021.113216 are less likely to be essential than older genes, and duplicates
25. Liu Y, Du Y, Hu X, Zhao L, Xia W. Up-regulation of ceRNA are less likely to be essential than singletons of the same age.
TINCR by SP1 contributes to tumorigenesis in breast cancer. Mol Biol Evol. 2012;29(7):1703-1706.
BMC Cancer. 2018;18:367. doi: 10.1093/molbev/mss014
doi: 10.1186/s12885-018-4255-3 37. Kanehisa M, Araki M, Goto S, et al. KEGG for linking
genomes to life and the environment. Nucleic Acids Res.
26. Mesquita FP, Moreira-Nunes CA, da Silva EL, et al. MAPK14
(p38α) inhibition effects against metastatic gastric cancer 2007;36(suppl 1):D480-D484.
cells: A potential biomarker and pharmacological target. 38. Petrucelli N, Daly MB, Pal T. BRCA1-and BRCA2-Associated
Toxicol In Vitro. 2020;66:104839. Hereditary Breast and Ovarian Cancer. Seattle, WA:
doi: 10.1016/j.tiv.2020.104839 University of Washington; 2022.
27. Blake JA, Bult CJ, Eppig JT, Kadin JA, Richardson JE, 39. Peto J, Collins N, Barfoot R, et al. Prevalence of BRCA1 and
Mouse Genome Database Group. The mouse genome BRCA2 gene mutations in patients with early-onset breast
database genotypes: Phenotypes. Nucleic Acids Res. cancer. J Natl Cancer Inst. 1999;91(11):943-949.
2009;37(Suppl 1):D712-D719. doi: 10.1093/jnci/91.11.943
doi: 10.1093/nar/gkn886 40. Couch FJ, Shimelis H, Hu C, et al. Associations between
28. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. cancer predisposition testing panel genes and breast cancer.
Nature. 2001;411(6835):355-365. JAMA Oncol. 2017;3(9):1190-1196.
doi: 10.1038/35077225 doi: 10.1001/jamaoncol.2017.0424
29. Sebolt-Leopold JS, Herrera R. Targeting the mitogen- 41. Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL. ERK/
activated protein kinase cascade to treat cancer. Nat Rev MAPK signalling pathway and tumorigenesis. Exp Ther
Cancer. 2004;4(12):937-947. Med. 2020;19(3):1997-2007.
doi: 10.1038/nrc1503 doi: 10.3892/etm.2020.8454
30. Foulstone E, Prince S, Zaccheo O, et al. Insulin‐like growth 42. Lee S, Rauch J, Kolch W. Targeting MAPK signaling in
factor ligands, receptors, and binding proteins in cancer. cancer: Mechanisms of drug resistance and sensitivity. Int J
J Pathol. 2005;205(2):145-153. Mol Sci. 2020;21(3):1102.
doi: 10.1002/path.1712 doi: 10.3390/ijms21031102
31. Lapenna S, Giordano A. Cell cycle kinases as therapeutic 43. Mukherjee CS, Zhang J. A multi-core periphery perspective:
targets for cancer. Nat Rev Drug Discov. 2009;8(7):547-566. Ranking via relative centrality. arXiv preprint. 2024;
arXiv:2406.04487.
doi: 10.1038/nrd2907
44. Zhao L, Yang Y, Bai X, et al. Structure, robustness and supply
32. Min J, Zaslavsky A, Fedele G, et al. An oncogene-tumor risk in the global wind turbine trade network. Renew Sustain
suppressor cascade drives metastatic prostate cancer by Energy Rev. 2023;177:113214.
coordinately activating Ras and nuclear factor-κB. Nat Med.
2010;16(3):286-294. 45. Brown RE, Short SP, Williams CS. Colorectal cancer and
metabolism. Curr Colorectal Cancer Rep. 2018;14:226-241.
doi: 10.1038/nm.2100
doi: 10.1007/s11888-018-0420-y
33. Münger K. Disruption of oncogene/tumor suppressor
networks during human carcinogenesis. Cancer Investig. 46. Blevins AS, Kim JZ, Bassett DS. Variability in higher order
2002;20(1):71-81. structure of noise added to weighted networks. Commun
Phys. 2021;4(1):233.
doi: 10.1081/cnv-120000369
47. Ramos RH, Ferreira COL, Simao A. Human protein-protein
34. Lee EY, Muller WJ. Oncogenes and tumor suppressor genes. interaction networks: A topological comparison review.
Cold Spring Harb Perspect Biol. 2010;2(10):a003236. Heliyon. 2024;10(5):e27278.
doi: 10.1101/cshperspect.a003236
48. Fadhal E, Gamieldien J, Mwambene EC. Self-similarity of
35. Chen WH, Lu G, Chen X, Zhao XM, Bork P. OGEE v2: An human protein interaction networks: A novel strategy of
update of the online gene essentiality database with special distinguishing proteins. Sci Rep. 2015;5(1):7628.

Volume 9 Issue 3 (2025) 84 doi: 10.36922/ejmo.8208